JP2008520241A5 - - Google Patents

Download PDF

Info

Publication number
JP2008520241A5
JP2008520241A5 JP2007543209A JP2007543209A JP2008520241A5 JP 2008520241 A5 JP2008520241 A5 JP 2008520241A5 JP 2007543209 A JP2007543209 A JP 2007543209A JP 2007543209 A JP2007543209 A JP 2007543209A JP 2008520241 A5 JP2008520241 A5 JP 2008520241A5
Authority
JP
Japan
Prior art keywords
antibody
medicament according
antibody fragment
domain
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007543209A
Other languages
English (en)
Other versions
JP2008520241A (ja
JP5341350B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/041594 external-priority patent/WO2006055665A2/en
Publication of JP2008520241A publication Critical patent/JP2008520241A/ja
Publication of JP2008520241A5 publication Critical patent/JP2008520241A5/ja
Application granted granted Critical
Publication of JP5341350B2 publication Critical patent/JP5341350B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (5)

  1. ンドセリン−1/アンジオテンシンII二重レセプター(Dear)ET−1ドメインへの結合をブロッキングできる抗体または抗体フラグメントを含む、個体における血管新生を阻害するための医薬
  2. 抗体または抗体フラグメントがヒト化抗体またはヒト化抗体フラグメントである、請求項に記載の医薬
  3. 血管新生は、免疫および非免疫炎症、慢性関節リューマチ、乾癬、糖尿病性網膜症、血管新生緑内症、再発狭窄症、黄班変性、アテローム性動脈硬化プラークにおける毛細管増殖、骨粗鬆症、癌、充実性腫瘍、充実性腫瘍転移、血管線維腫、水晶体後方線維増殖症、血管腫およびカポジ肉腫からなる群より選ばれる疾患または障害と関連している、請求項に記載の医薬
  4. 抗体または抗体フラグメントが配列番号2のET−1ドメインへの結合をブロッキングする、請求項1に記載の医薬
  5. ET−1ドメインが配列番号2のアミノ酸60〜67を含む、請求項1に記載の医薬
JP2007543209A 2004-11-16 2005-11-15 高血圧および血管新生におけるエンドセリン−1/アンジオテンシンii二重レセプター(dear)の役割 Active JP5341350B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62844704P 2004-11-16 2004-11-16
US60/628,447 2004-11-16
US69426805P 2005-06-27 2005-06-27
US60/694,268 2005-06-27
PCT/US2005/041594 WO2006055665A2 (en) 2004-11-16 2005-11-15 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012168420A Division JP2012233000A (ja) 2004-11-16 2012-07-30 高血圧および血管新生におけるエンドセリン−1/アンジオテンシンii二重レセプター(dear)の役割

Publications (3)

Publication Number Publication Date
JP2008520241A JP2008520241A (ja) 2008-06-19
JP2008520241A5 true JP2008520241A5 (ja) 2011-03-17
JP5341350B2 JP5341350B2 (ja) 2013-11-13

Family

ID=36407731

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007543209A Active JP5341350B2 (ja) 2004-11-16 2005-11-15 高血圧および血管新生におけるエンドセリン−1/アンジオテンシンii二重レセプター(dear)の役割
JP2012168420A Pending JP2012233000A (ja) 2004-11-16 2012-07-30 高血圧および血管新生におけるエンドセリン−1/アンジオテンシンii二重レセプター(dear)の役割

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012168420A Pending JP2012233000A (ja) 2004-11-16 2012-07-30 高血圧および血管新生におけるエンドセリン−1/アンジオテンシンii二重レセプター(dear)の役割

Country Status (6)

Country Link
US (3) US7919093B2 (ja)
EP (2) EP1812473A4 (ja)
JP (2) JP5341350B2 (ja)
AU (1) AU2005307765C1 (ja)
CA (1) CA2588066A1 (ja)
WO (1) WO2006055665A2 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2390425T3 (es) * 2000-12-22 2012-11-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Uso de moléculas de orientación repulsivas (RGM) y sus moduladores
EP1928905B1 (de) * 2005-09-30 2015-04-15 AbbVie Deutschland GmbH & Co KG Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
ES2550004T3 (es) 2006-04-04 2015-11-03 Singulex, Inc. Sistema de alta sensibilidad y métodos de análisis de la troponina
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
EP2033971A1 (de) * 2007-09-06 2009-03-11 Abbott GmbH & Co. KG Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
US8962803B2 (en) * 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
MX2012006560A (es) * 2009-12-08 2012-10-05 Abbott Gmbh & Co Kg Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
WO2012012750A1 (en) * 2010-07-23 2012-01-26 Trustees Of Boston University ANTI-DEsupR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY
US20130022551A1 (en) * 2011-07-22 2013-01-24 Trustees Of Boston University DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS
MX352772B (es) 2012-01-27 2017-12-07 Abbvie Deutschland Composición y método para el diagnóstico y tratamiento de enfermedades asociadas con la degeneración de neuritas.
AU2016311265B2 (en) * 2015-08-24 2023-03-16 Trustees Of Boston University Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke
JP7404230B2 (ja) 2017-09-18 2023-12-25 トラスティーズ オブ ボストン ユニバーシティ ネトーシスおよび好中球活性化を処置するための方法
US10953107B2 (en) 2018-06-15 2021-03-23 Trustees Of Boston University Polypeptide compositions and methods for site-specific targeting of therapeutic agents
WO2022081792A1 (en) 2020-10-15 2022-04-21 Trustees Of Boston University Antibody therapies and methods for treating coronavirus infection
CN116530469B (zh) * 2023-07-06 2023-09-19 首都医科大学 腹主动脉瘤动物模型的制备方法与应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3625214A (en) 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
US4543439A (en) 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4906474A (en) 1983-03-22 1990-03-06 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4902614A (en) 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4789734A (en) 1985-08-06 1988-12-06 La Jolla Cancer Research Foundation Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
NO870613L (no) 1986-03-05 1987-09-07 Molecular Diagnostics Inc Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre.
EP0318512B1 (en) 1986-08-18 1998-06-17 Emisphere Technologies, Inc. Delivery systems for pharmacological agents
DE68928853T2 (de) 1988-05-20 1999-08-05 Cetus Corp Befestigung von sequenzspezifischen proben
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5440021A (en) * 1991-03-29 1995-08-08 Chuntharapai; Anan Antibodies to human IL-8 type B receptor
ATE198358T1 (de) 1992-04-27 2001-01-15 Dartmouth College Detektion von gensequenzen in biologischen flüssigkeiten
US5593688A (en) 1993-06-25 1997-01-14 Nexstar Pharmaceuticals, Inc. Liposomal targeting of ischemic tissue
DE69433180T2 (de) 1993-10-26 2004-06-24 Affymetrix, Inc., Santa Clara Felder von nukleinsaeuresonden auf biologischen chips
EP0897567A2 (en) 1996-04-19 1999-02-24 Spectra Biomedical, Inc. Correlating polymorphic forms with multiple phenotypes
EP0979869A1 (en) 1998-08-07 2000-02-16 Hoechst Marion Roussel Deutschland GmbH Short oligonucleotides for the inhibition of VEGF expression
US6641811B1 (en) * 2000-02-10 2003-11-04 Cornell Research Foundation, Inc. Use of angiotensin II inhibitors to prevent malignancies associated with immunosuppression

Similar Documents

Publication Publication Date Title
JP2008520241A5 (ja)
JP2022031635A5 (ja)
MX2009002711A (es) Anticuerpos anti-receptor de folato alfa humanos y fragmentos de anticuerpo para la radioinmunoterapia de carcinoma de ovario.
NL300911I2 (nl) sarilumab
HRP20130922T1 (hr) U potpunosti humana protutijela protiv humanog 4-1bb (cd137)
WO2007062245A3 (en) Human monoclonal antibody human cd134 (ox40) and methods of making and using same
JP2010507594A5 (ja)
JP2007535490A5 (ja)
HRP20170524T1 (hr) Humana protutijela koja vežu humani protein 4 nalik angiopoietinu
JP2019504032A5 (ja)
JP2009521496A5 (ja)
JP2005515963A5 (ja)
JP2006505545A5 (ja)
JP2008516970A5 (ja)
CY1113224T1 (el) Νεο αντισωμα αντι-ρlgf
JP2013519364A5 (ja)
AR052959A1 (es) Anticuerpos anti- ccr5 y usos de los mismos
WO2008140653A3 (en) Humaneered anti-factor b antibody
GT200500255A (es) Anticuerpos anti-5ta humanizados y conjugados anticuerpo anti-5ta/calicheamicina
JP2009518005A5 (ja)
JP2006524039A5 (ja)
JP2014500009A5 (ja)
JP2019525957A5 (ja)
WO2006066568A3 (de) Monokonale agonistische anti-ctla-4 antikörper
EP1790663A4 (en) MONOCLONAL ANTIBODY (AD5-10) AGAINST THE TUMOR NEKROSIS FACTOR RELATED APOPTOSIS-INDUCING LIGAND RESPECTOR DR5, METHOD OF MANUFACTURE AND APPLICATIONS THEREOF